(Q34232133)

31 July 2017

1 reference

title

Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology (English)

1 reference

31 July 2017

1 reference

1 reference

3

Larsson R

1 reference

31 July 2017

2

Nygren P

1 reference

31 July 2017

Ekelund S

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

31 July 2017

published in

Biochemical Pharmacology

1 reference

31 July 2017

volume

61

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

1183-1193

1 reference

Mitochondrial effects of the guanidino group-containing cytostatic drugs, m-iodobenzylguanidine and methylglyoxal bis (guanylhydrazone)

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Polyamines: from molecular biology to clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodo-benzylguanidine (MIBG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Renal toxicity of the neuron-blocking and mitochondriotropic agent m-iodobenzylguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Intracellular inhibition of mono(ADP-ribosylation) by meta-iodobenzylguanidine: specificity, intracellular concentration and effects on glucocorticoid-mediated cell lysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Meta-iodobenzylguanidine (MIBG) inhibits malate and succinate driven mitochondrial ATP synthesis in the human neuroblastoma cell line SK-N-BE(2c)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

MIBG causes oxidative stress and up-regulation of anti-oxidant enzymes in the human neuroblastoma cell line SK-N-BE(2c).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Meta-iodobenzylguanidine inhibits complex I and III of the respiratory chain in the human cell line Molt-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Impaired mitochondrial respiration and stimulated glycolysis by m-iodobenzylguanidine (MIBG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Reduction of tumour intracellular pH and enhancement of melphalan cytotoxicity by the ionophore Nigericin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Induction of transient hyperglycaemia in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: comparison with m-iodobenzylguanidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Keilin's Respiratory Chain Concept and Its Chemiosmotic Consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

The mitochondrial electron transport and oxidative phosphorylation system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

MIBG inhibits respiration: potential for radio- and hyperthermic sensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Lactate-induced inhibition of tumor cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Potentiation of glucocorticoid-induced lysis in refractory and resistant leukemia cells by inhibitors of ADP-ribosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

The effect of the neuroblastoma-seeking agent meta-iodobenzylguanidine (MIBG) on NADH-driven superoxide formation and NADH-driven lipid peroxidation in beef heart submitochondrial particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Scintigraphic Localization of Pheochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Polyamine metabolism and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Methylglyoxal-bis(guanylhydrazone) (Methyl-GAG): current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

What do the polyamines do?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Use of aminopropyltransferase inhibitors and of non-metabolizable analogs to study polyamine regulation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Aspects of the biochemical pharmacology of methyl glyoxal bis(guanylhydrazone).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Relation of the antiproliferative action of methylglyoxal-bis(guanylhydrazone) to the natural polyamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

S-adenosylmethionine decarboxylase as target of chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Specific inhibition of the enzymic decarboxylation of S-adenosylmethionine by methylglyoxal bis(guanylhydrazone) and related substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Diethylglyoxal bis(guanylhydrazone), a potent inhibitor of mammalian S-adenosylmethionine decarboxylase. Effects on cell proliferation and polyamine metabolism in L1210 leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Alterations in repair of alkylating agent-induced DNA damage in polyamine-depleted human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Increased spermidine or spermine level is essential for hepatocyte growth factor-induced DNA synthesis in cultured rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Inhibition by derivatives of diguanidines of cell proliferation in Ehrlich ascites cells grown in cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

The possible role of intracellular polyamines in mitochondrial metabolic regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Protective action of methylglyoxal bis (guanylhydrazone) on the mitochondrial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Enhanced uptake of spermidine and methylglyoxal-bis(guanylhydrazone) by rat liver mitochondria following outer membrane lysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Actions of bis(guanylhydrazones) on isolated rat liver mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Polyamines regulate human medullary thyroid carcinoma TT-cell proliferation and secretion of calcitonin and calcitonin gene-related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

The effects of methylglyoxal-bis(guanylhydrazone) on spermine binding and transport in liver mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Spermine binding to liver mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Phase II trials of methylglyoxal-bis (guanylhydrazone)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study. Swedish Lymphoma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Carbohydrate metabolism in cultured animal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

Induction of apoptotic cell death in human hepatocellular carcinoma SK-HEP-1 cells by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900570-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(01)00570-6

1 reference

31 July 2017

1 reference